CMS has advised Robyg, Bank Pekao, and mBank on the company's PLN 110 million bond issuance.

Former Counsel Wojciech Marchwicki has been appointed as a Partner with the Hogan Lovells Warsaw office as of January 1, 2023.

Former Hoogells Lawyer Michal Wojciechowski has joined Eversheds Sutherland as a Counsel and the firm’s new Head of Public Contracts.

Clifford Chance has advised Airbus Defence and Space on the sale of two observation satellites and related systems and services to the Polish Armament Agency.

Greenberg Traurig has advised Allianz on the mergers of the respective companies within the Allianz Group and Aviva Group in Poland.

As a rule, medical device advertising can be conducted by economic operators, i.e. manufacturers, distributors, authorized representatives and importers (Article 56 (1) of the Polish Medical Devices Act of 7 April 2022 (the MDA)). Other entities can conduct advertising only after approval of the advertisement in writing by the economic operators.

Kozlowski Tomasik Oszczak has advised Columbus Energy on its sale of a 102.5-megawatt photovoltaic farms portfolio to Engie Zielona Energia. Domanski Zakrzewski Palinka reportedly advised the buyer.

Wardynski & Partners has advised the Bucher Group on its acquisition of B&P Engineering. CMS advised B&P Engineering's shareholders.

As in the case of EU Regulations 2017/745 on medical devices (the MDR) and 2017/746 on in vitro diagnostic medical devices (the IVDR), the Polish Medical Devices Act of 7 April 2022 (the MDA) does not provide any definition of advertising. It can therefore be difficult for the industry to understand in practice which activities are likely to be treated as advertising by the regulatory authorities. Whilst the new legislation provides for stricter rules for advertising addressed to the general public, the MDA fails to provide guidance on what the advertising to the general public in fact is and determine a clear distinction between such activities and the advertising directed to non-laymen.

1 January 2023 brought a major change to medical device advertising in Poland. From this date, the new national regime for medical device advertising applies. Therefore, all promotional activities associated with medical devices in Poland need to comply not only with the European Union regulations, but also with the new national requirements.

Clifford Chance has advised Polish apartment rental company Resi4Rent on obtaining EUR 50 million in financing from the EBRD. DLA Piper reportedly advised the lender.

Gessel has advised Pure Biologics on its public offering of shares carried out under an accelerated book-building program and the private offering of new company shares. Jonak i Partnerzy advised the managers.

Clifford Chance has advised Ipopema Securities on the establishment of an up to PLN 500 million bond issuance program for Echo Investment and Echo's first PLN 180 million issuance of bonds under the program.

Greenberg Traurig has advised CVC Capital Partners on its sale of the PKP Energetyka power company to state-owned PGE Polska Grupa Energetyczna. Rymarz Zdort advised PGE.

Wardynski & Partners, working with Latham & Watkins, has advised Spider Investments Luxembourg on its EUR 1.88 billion sale of Transporeon to Trimble.

According to publicly available research reports, Poland holds the seventh place in terms of the number of experts working on artificial intelligence (AI) projects in the European Union and even takes the lead in CEE. On the other hand, the level of adoption of AI-based solutions by Polish businesses is relatively disproportionate. The estimations made by the government visualize the potential impact of AI on the Polish economy. According to these calculations, the implementation of AI solutions in the Polish economy could contribute to increasing the GDP growth rate by 2.65% annually.

Balicki Czekanski Gryglewski Lewczuk has advised Adamed on a minority investment in Apeiron Synthesis as part of a PLN 21 million round that also included Aper Ventures and Orlen VC. Lewczuk Lyszczarek i Wspolnicy advised Apeiron Synthesis.

Act BSWW has advised Develia on its public placement of bonds worth PLN 15.4 million.